Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 310769)

Published in Genome Res on May 01, 1999

Authors

T G Paulson1, P C Galipeau, B J Reid

Author Affiliations

1: Programs in Cancer Biology and GI Oncology, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA.

Articles citing this

Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A (2002) 13.58

Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci U S A (2004) 2.27

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med (2007) 2.23

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol (2001) 2.17

Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13

Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44

Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) (2008) 1.43

Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am J Pathol (2002) 1.39

RNA-Seq identifies SNP markers for growth traits in rainbow trout. PLoS One (2012) 1.25

Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet (2006) 1.21

FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia. Blood (2006) 1.17

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Acta Neuropathol (2013) 1.03

Loss of heterozygosity analyzed by single nucleotide polymorphism array in cancer. World J Gastroenterol (2005) 1.02

Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Hum Mutat (2011) 1.01

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst (2003) 0.99

Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. World J Gastroenterol (2010) 0.98

Direct amplification of single-stranded DNA for pyrosequencing using linear-after-the-exponential (LATE)-PCR. Anal Biochem (2006) 0.90

Deletion at fragile sites is a common and early event in Barrett's esophagus. Mol Cancer Res (2010) 0.89

Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res (2000) 0.88

p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One (2008) 0.87

Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations. Cell Oncol (Dordr) (2011) 0.87

Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity. Cancer Biomark (2009) 0.87

Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer (2000) 0.85

Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. Semin Cancer Biol (2010) 0.83

Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system. J Mol Diagn (2007) 0.79

Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective. Cell Mol Gastroenterol Hepatol (2017) 0.77

Identification of SNPs associated with muscle yield and quality traits using allelic-imbalance analyses of pooled RNA-Seq samples in rainbow trout. BMC Genomics (2017) 0.75

Articles cited by this

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53

Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A (1992) 9.15

Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32

Reliable genotyping of samples with very low DNA quantities using PCR. Nucleic Acids Res (1996) 5.73

Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12

Chromosome-specific microsatellite sets for fluorescence-based, semi-automated genome mapping. Nat Genet (1994) 4.45

Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67

Loss of constitutional heterozygosity in human cancer. Annu Rev Genet (1991) 2.77

Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology (1992) 2.57

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53

Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures. Biotechniques (1993) 2.24

A study of the origin of 'shadow bands' seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Mol Genet (1993) 2.22

Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol (1990) 2.13

Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology (1993) 2.00

Allele frequency distributions in pooled DNA samples: applications to mapping complex disease genes. Genome Res (1998) 1.81

Nucleic acid-based methods for the detection of cancer. Science (1997) 1.80

Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56

Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci U S A (1996) 1.53

17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52

Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene (1996) 1.46

Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am (1991) 1.42

An approach to high-throughput genotyping. Genome Res (1996) 1.40

Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase. Genome Res (1995) 1.33

Comparison of fluorescence-based semi-automated genotyping of multiple microsatellite loci with autoradiographic techniques. Genomics (1994) 1.30

Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res (1995) 1.24

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer (1997) 1.13

Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res (1998) 1.13

Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. Cytometry (1996) 1.08

Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53. Biotechniques (1995) 0.92

Barrett's esophagus: the biology of neoplastic progression. Gastroenterol Clin Biol (1994) 0.85

Proliferative cell indices measured by DNA flow cytometry in node-negative adenocarcinomas of breast: accuracy and significance in cytokeratin-stained archival specimens. Mod Pathol (1994) 0.81

Articles by these authors

Genetic control of the cell division cycle in yeast. Science (1974) 13.83

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41

A p53-dependent mouse spindle checkpoint. Science (1995) 4.01

Regulation of mating in the cell cycle of Saccharomyces cerevisiae. J Cell Biol (1977) 3.68

Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53

Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol (2001) 2.17

Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15

Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13

p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05

Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03

Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol (1986) 1.91

Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest (1989) 1.83

Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75

p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res (1997) 1.67

Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65

p53-mutant clones and field effects in Barrett's esophagus. Cancer Res (1999) 1.61

Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol (1999) 1.56

Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56

Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A (1991) 1.53

17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52

Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res (1994) 1.49

Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene (1996) 1.46

Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44

p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology (1994) 1.43

Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40

17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res (1991) 1.39

Barrett's esophagus: ordering the events that lead to cancer. Eur J Cancer Prev (1996) 1.39

Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene (1996) 1.32

Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol (2000) 1.25

Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay. Histopathology (1990) 1.24

Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res (1995) 1.24

Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology (1998) 1.24

Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res (1996) 1.14

Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology (1991) 1.11

Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol (1988) 1.10

High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues. Biotechniques (2002) 1.08

The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer (1994) 1.05

Multiple keratoacanthomata. A unique case and review of the current classification. Acta Derm Venereol (1978) 1.04

Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest (1989) 0.99

Impact of composting strategies on the treatment of soils contaminated with organic pollutants. Environ Pollut (2001) 0.99

Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res (1991) 0.99

Barrett's esophagus and adenocarcinoma. Annu Rev Med (1987) 0.99

Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc (1991) 0.97

Barrett's esophagus: a model of human neoplastic progression. Cold Spring Harb Symp Quant Biol (1994) 0.97

Biomarkers in Barrett esophagus. Mayo Clin Proc (2001) 0.97

Persistent clonal areas and clonal expansion in Barrett's esophagus. Cancer Res (1992) 0.97

Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. Gastroenterology (1989) 0.97

Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus. Nutr Cancer (2000) 0.94

Application of a luminescence-based biosensor for assessing naphthalene biodegradation in soils from a manufactured gas plant. Environ Pollut (2009) 0.90

p53 and neoplastic progression in Barrett's esophagus. Am J Gastroenterol (2001) 0.89

Study of tinea capitis in Philadelphia using case and control groups. Public Health Rep (1968) 0.87

Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas. Pancreas (1995) 0.86

Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci (1989) 0.86

Actinic granuloma in association with giant cell arteritis: are both caused by sunlight? Pathology (1997) 0.86

Flow-cytometric DNA content analysis of esophageal squamous cell carcinomas. Gastroenterology (1991) 0.85

Barrett's esophagus: the biology of neoplastic progression. Gastroenterol Clin Biol (1994) 0.85

Loss of heterozygosity in childhood de novo acute myelogenous leukemia. Blood (2001) 0.83

Oxytetracycline in the treatment of ocular rosacea: a double-blind trial. Br J Ophthalmol (1982) 0.82

Unfamiliar aspects of familial polyposis coli. Am J Surg (1986) 0.78

Exophiala werneckii causing tinea nigra in Scotland. Br J Dermatol (1998) 0.78

Comparison of selected non-exhaustive extraction techniques to assess PAH availability in dissimilar soils. Chemosphere (2005) 0.75

A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma. IEEE Trans Biomed Eng (2001) 0.75

Letter: Tetracyclines in gonorrhea therapy. N Engl J Med (1976) 0.75

Re: 'Competence of Nursing Graduates in Technical, Communicative, and Administrative Skills'. Nurs Res (1979) 0.75

New record for Aedes thelcter in Arizona. J Am Mosq Control Assoc (1990) 0.75

The influence of a NAPL on the loss and biodegradation of 14C-phenanthrene residues in two dissimilar soils. Chemosphere (2007) 0.75

Potential sources of type I error and possible solutions to avoid a "galloping" alpha rate. Nurs Res (1983) 0.75